KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 142 filers reported holding KURA ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,983,615 | -13.8% | 1,423,642 | 0.0% | 1.91% | -22.6% |
Q2 2023 | $15,062,132 | -13.5% | 1,423,642 | 0.0% | 2.47% | -27.2% |
Q1 2023 | $17,411,142 | -1.5% | 1,423,642 | 0.0% | 3.39% | +8.9% |
Q4 2022 | $17,667,397 | -4.1% | 1,423,642 | +5.6% | 3.12% | -43.6% |
Q3 2022 | $18,422,000 | -13.9% | 1,348,642 | +15.5% | 5.52% | -39.2% |
Q2 2022 | $21,403,000 | +162.8% | 1,167,642 | +130.6% | 9.09% | +178.1% |
Q1 2022 | $8,143,000 | – | 506,423 | – | 3.27% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |